Loading…

Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey

Background Cutaneous leishmaniasis (CL) is a vector‐born parasitic disease characterized by various skin lesions that cause disfiguration if healed spontaneously. Although CL has been endemic for many years in the southern regions of Turkey, an increasing incidence in nonendemic regions is being obs...

Full description

Saved in:
Bibliographic Details
Published in:International journal of dermatology 2018-08, Vol.57 (8), p.973-982
Main Authors: Uzun, Soner, Gürel, Mehmet S., Durdu, Murat, Akyol, Melih, Fettahlıoğlu Karaman, Bilge, Aksoy, Mustafa, Aytekin, Sema, Borlu, Murat, İnan Doğan, Esra, Doğramacı, Çiğdem Asena, Kapıcıoğlu, Yelda, Akman‐Karakaş, Ayşe, Kaya, Tamer İ., Mülayim, Mehmet K., Özbel, Yusuf, Özensoy Töz, Seray, Özgöztaşı, Orhan, Yeşilova, Yavuz, Harman, Mehmet
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3532-bbfea5701c92eeebde9e83748e013501646f910aca3b034cdcb4e8dcf2f6b39d3
cites cdi_FETCH-LOGICAL-c3532-bbfea5701c92eeebde9e83748e013501646f910aca3b034cdcb4e8dcf2f6b39d3
container_end_page 982
container_issue 8
container_start_page 973
container_title International journal of dermatology
container_volume 57
creator Uzun, Soner
Gürel, Mehmet S.
Durdu, Murat
Akyol, Melih
Fettahlıoğlu Karaman, Bilge
Aksoy, Mustafa
Aytekin, Sema
Borlu, Murat
İnan Doğan, Esra
Doğramacı, Çiğdem Asena
Kapıcıoğlu, Yelda
Akman‐Karakaş, Ayşe
Kaya, Tamer İ.
Mülayim, Mehmet K.
Özbel, Yusuf
Özensoy Töz, Seray
Özgöztaşı, Orhan
Yeşilova, Yavuz
Harman, Mehmet
description Background Cutaneous leishmaniasis (CL) is a vector‐born parasitic disease characterized by various skin lesions that cause disfiguration if healed spontaneously. Although CL has been endemic for many years in the southern regions of Turkey, an increasing incidence in nonendemic regions is being observed due to returning travelers and, more recently, due to Syrian refugees. Thus far, a limited number of national guidelines have been proposed, but no common Turkish consensus has emerged. Objectives The aim of this study was to develop diagnostic and therapeutic guidelines for the management of CL in Turkey. Methods This guideline is a consensus text prepared by 18 experienced CL specialists who have been working for many years in areas where the disease is endemic. The Delphi method was used to determine expert group consensus. Initially, a comprehensive list of items about CL was identified, and consensus was built from feedback provided by expert participants from the preceding rounds. Results Evidence‐based and expert‐based recommendations through diagnostic and therapeutic algorithms according to local availability and conditions are outlined. Conclusion Because CL can mimic many other skin diseases, early diagnosis and early treatment are very important to prevent complications and spread of the disease. The fastest and easiest diagnostic method is the leishmanial smear. The most common treatment is the use of local or systemic pentavalent antimony compounds.
doi_str_mv 10.1111/ijd.14002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2026415177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2066447110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3532-bbfea5701c92eeebde9e83748e013501646f910aca3b034cdcb4e8dcf2f6b39d3</originalsourceid><addsrcrecordid>eNp10E1LwzAcBvAgipvTg19AAl700C1vTdejzLfJwMs8lzT5d8vsy0xaZN_ezE4PgrmEhB8PDw9Cl5SMaTgTuzFjKghhR2hIuYwjITk7RkNCKI1SEqcDdOb9Jjw5o-IUDVgqJecxHSI1K21ttSrx1indWg141VkD4Rc8LhqH2zVgY9Wqbrz1WNUGtw5UW0Hd4qbAumtVDU3ncQnWrytVW7WHtsbLzr3D7hydFKr0cHG4R-jt8WE5e44Wr0_z2d0i0jzmLMrzAlScEKpTBgC5gRSmPBFTCK1jQqWQRUqJ0ornhAttdC5ganTBCpnz1PARuulzt6756MC3WWW9hrLs62WMMCloTJMk0Os_dNN0rg7tgpJSiIRSEtRtr7RrvHdQZFtnK-V2GSXZfvcs7J597x7s1SGxyyswv_Jn6AAmPfi0Jez-T8rmL_d95Be_To0d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2066447110</pqid></control><display><type>article</type><title>Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey</title><source>Wiley</source><creator>Uzun, Soner ; Gürel, Mehmet S. ; Durdu, Murat ; Akyol, Melih ; Fettahlıoğlu Karaman, Bilge ; Aksoy, Mustafa ; Aytekin, Sema ; Borlu, Murat ; İnan Doğan, Esra ; Doğramacı, Çiğdem Asena ; Kapıcıoğlu, Yelda ; Akman‐Karakaş, Ayşe ; Kaya, Tamer İ. ; Mülayim, Mehmet K. ; Özbel, Yusuf ; Özensoy Töz, Seray ; Özgöztaşı, Orhan ; Yeşilova, Yavuz ; Harman, Mehmet</creator><creatorcontrib>Uzun, Soner ; Gürel, Mehmet S. ; Durdu, Murat ; Akyol, Melih ; Fettahlıoğlu Karaman, Bilge ; Aksoy, Mustafa ; Aytekin, Sema ; Borlu, Murat ; İnan Doğan, Esra ; Doğramacı, Çiğdem Asena ; Kapıcıoğlu, Yelda ; Akman‐Karakaş, Ayşe ; Kaya, Tamer İ. ; Mülayim, Mehmet K. ; Özbel, Yusuf ; Özensoy Töz, Seray ; Özgöztaşı, Orhan ; Yeşilova, Yavuz ; Harman, Mehmet</creatorcontrib><description>Background Cutaneous leishmaniasis (CL) is a vector‐born parasitic disease characterized by various skin lesions that cause disfiguration if healed spontaneously. Although CL has been endemic for many years in the southern regions of Turkey, an increasing incidence in nonendemic regions is being observed due to returning travelers and, more recently, due to Syrian refugees. Thus far, a limited number of national guidelines have been proposed, but no common Turkish consensus has emerged. Objectives The aim of this study was to develop diagnostic and therapeutic guidelines for the management of CL in Turkey. Methods This guideline is a consensus text prepared by 18 experienced CL specialists who have been working for many years in areas where the disease is endemic. The Delphi method was used to determine expert group consensus. Initially, a comprehensive list of items about CL was identified, and consensus was built from feedback provided by expert participants from the preceding rounds. Results Evidence‐based and expert‐based recommendations through diagnostic and therapeutic algorithms according to local availability and conditions are outlined. Conclusion Because CL can mimic many other skin diseases, early diagnosis and early treatment are very important to prevent complications and spread of the disease. The fastest and easiest diagnostic method is the leishmanial smear. The most common treatment is the use of local or systemic pentavalent antimony compounds.</description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.14002</identifier><identifier>PMID: 29663351</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Antimony ; Antimony compounds ; Clinical practice guidelines ; Complications ; Cutaneous leishmaniasis ; Delphi method ; Diagnosis ; Diagnostic systems ; Guidelines ; Lesions ; Medical treatment ; Parasitic diseases ; Refugees ; Skin diseases ; Smear ; Vector-borne diseases</subject><ispartof>International journal of dermatology, 2018-08, Vol.57 (8), p.973-982</ispartof><rights>2018</rights><rights>2018 The International Society of Dermatology.</rights><rights>International Journal of Dermatology © 2018 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3532-bbfea5701c92eeebde9e83748e013501646f910aca3b034cdcb4e8dcf2f6b39d3</citedby><cites>FETCH-LOGICAL-c3532-bbfea5701c92eeebde9e83748e013501646f910aca3b034cdcb4e8dcf2f6b39d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.14002$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.14002$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29663351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uzun, Soner</creatorcontrib><creatorcontrib>Gürel, Mehmet S.</creatorcontrib><creatorcontrib>Durdu, Murat</creatorcontrib><creatorcontrib>Akyol, Melih</creatorcontrib><creatorcontrib>Fettahlıoğlu Karaman, Bilge</creatorcontrib><creatorcontrib>Aksoy, Mustafa</creatorcontrib><creatorcontrib>Aytekin, Sema</creatorcontrib><creatorcontrib>Borlu, Murat</creatorcontrib><creatorcontrib>İnan Doğan, Esra</creatorcontrib><creatorcontrib>Doğramacı, Çiğdem Asena</creatorcontrib><creatorcontrib>Kapıcıoğlu, Yelda</creatorcontrib><creatorcontrib>Akman‐Karakaş, Ayşe</creatorcontrib><creatorcontrib>Kaya, Tamer İ.</creatorcontrib><creatorcontrib>Mülayim, Mehmet K.</creatorcontrib><creatorcontrib>Özbel, Yusuf</creatorcontrib><creatorcontrib>Özensoy Töz, Seray</creatorcontrib><creatorcontrib>Özgöztaşı, Orhan</creatorcontrib><creatorcontrib>Yeşilova, Yavuz</creatorcontrib><creatorcontrib>Harman, Mehmet</creatorcontrib><title>Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><description>Background Cutaneous leishmaniasis (CL) is a vector‐born parasitic disease characterized by various skin lesions that cause disfiguration if healed spontaneously. Although CL has been endemic for many years in the southern regions of Turkey, an increasing incidence in nonendemic regions is being observed due to returning travelers and, more recently, due to Syrian refugees. Thus far, a limited number of national guidelines have been proposed, but no common Turkish consensus has emerged. Objectives The aim of this study was to develop diagnostic and therapeutic guidelines for the management of CL in Turkey. Methods This guideline is a consensus text prepared by 18 experienced CL specialists who have been working for many years in areas where the disease is endemic. The Delphi method was used to determine expert group consensus. Initially, a comprehensive list of items about CL was identified, and consensus was built from feedback provided by expert participants from the preceding rounds. Results Evidence‐based and expert‐based recommendations through diagnostic and therapeutic algorithms according to local availability and conditions are outlined. Conclusion Because CL can mimic many other skin diseases, early diagnosis and early treatment are very important to prevent complications and spread of the disease. The fastest and easiest diagnostic method is the leishmanial smear. The most common treatment is the use of local or systemic pentavalent antimony compounds.</description><subject>Antimony</subject><subject>Antimony compounds</subject><subject>Clinical practice guidelines</subject><subject>Complications</subject><subject>Cutaneous leishmaniasis</subject><subject>Delphi method</subject><subject>Diagnosis</subject><subject>Diagnostic systems</subject><subject>Guidelines</subject><subject>Lesions</subject><subject>Medical treatment</subject><subject>Parasitic diseases</subject><subject>Refugees</subject><subject>Skin diseases</subject><subject>Smear</subject><subject>Vector-borne diseases</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp10E1LwzAcBvAgipvTg19AAl700C1vTdejzLfJwMs8lzT5d8vsy0xaZN_ezE4PgrmEhB8PDw9Cl5SMaTgTuzFjKghhR2hIuYwjITk7RkNCKI1SEqcDdOb9Jjw5o-IUDVgqJecxHSI1K21ttSrx1indWg141VkD4Rc8LhqH2zVgY9Wqbrz1WNUGtw5UW0Hd4qbAumtVDU3ncQnWrytVW7WHtsbLzr3D7hydFKr0cHG4R-jt8WE5e44Wr0_z2d0i0jzmLMrzAlScEKpTBgC5gRSmPBFTCK1jQqWQRUqJ0ornhAttdC5ganTBCpnz1PARuulzt6756MC3WWW9hrLs62WMMCloTJMk0Os_dNN0rg7tgpJSiIRSEtRtr7RrvHdQZFtnK-V2GSXZfvcs7J597x7s1SGxyyswv_Jn6AAmPfi0Jez-T8rmL_d95Be_To0d</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Uzun, Soner</creator><creator>Gürel, Mehmet S.</creator><creator>Durdu, Murat</creator><creator>Akyol, Melih</creator><creator>Fettahlıoğlu Karaman, Bilge</creator><creator>Aksoy, Mustafa</creator><creator>Aytekin, Sema</creator><creator>Borlu, Murat</creator><creator>İnan Doğan, Esra</creator><creator>Doğramacı, Çiğdem Asena</creator><creator>Kapıcıoğlu, Yelda</creator><creator>Akman‐Karakaş, Ayşe</creator><creator>Kaya, Tamer İ.</creator><creator>Mülayim, Mehmet K.</creator><creator>Özbel, Yusuf</creator><creator>Özensoy Töz, Seray</creator><creator>Özgöztaşı, Orhan</creator><creator>Yeşilova, Yavuz</creator><creator>Harman, Mehmet</creator><general>Blackwell Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201808</creationdate><title>Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey</title><author>Uzun, Soner ; Gürel, Mehmet S. ; Durdu, Murat ; Akyol, Melih ; Fettahlıoğlu Karaman, Bilge ; Aksoy, Mustafa ; Aytekin, Sema ; Borlu, Murat ; İnan Doğan, Esra ; Doğramacı, Çiğdem Asena ; Kapıcıoğlu, Yelda ; Akman‐Karakaş, Ayşe ; Kaya, Tamer İ. ; Mülayim, Mehmet K. ; Özbel, Yusuf ; Özensoy Töz, Seray ; Özgöztaşı, Orhan ; Yeşilova, Yavuz ; Harman, Mehmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3532-bbfea5701c92eeebde9e83748e013501646f910aca3b034cdcb4e8dcf2f6b39d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antimony</topic><topic>Antimony compounds</topic><topic>Clinical practice guidelines</topic><topic>Complications</topic><topic>Cutaneous leishmaniasis</topic><topic>Delphi method</topic><topic>Diagnosis</topic><topic>Diagnostic systems</topic><topic>Guidelines</topic><topic>Lesions</topic><topic>Medical treatment</topic><topic>Parasitic diseases</topic><topic>Refugees</topic><topic>Skin diseases</topic><topic>Smear</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uzun, Soner</creatorcontrib><creatorcontrib>Gürel, Mehmet S.</creatorcontrib><creatorcontrib>Durdu, Murat</creatorcontrib><creatorcontrib>Akyol, Melih</creatorcontrib><creatorcontrib>Fettahlıoğlu Karaman, Bilge</creatorcontrib><creatorcontrib>Aksoy, Mustafa</creatorcontrib><creatorcontrib>Aytekin, Sema</creatorcontrib><creatorcontrib>Borlu, Murat</creatorcontrib><creatorcontrib>İnan Doğan, Esra</creatorcontrib><creatorcontrib>Doğramacı, Çiğdem Asena</creatorcontrib><creatorcontrib>Kapıcıoğlu, Yelda</creatorcontrib><creatorcontrib>Akman‐Karakaş, Ayşe</creatorcontrib><creatorcontrib>Kaya, Tamer İ.</creatorcontrib><creatorcontrib>Mülayim, Mehmet K.</creatorcontrib><creatorcontrib>Özbel, Yusuf</creatorcontrib><creatorcontrib>Özensoy Töz, Seray</creatorcontrib><creatorcontrib>Özgöztaşı, Orhan</creatorcontrib><creatorcontrib>Yeşilova, Yavuz</creatorcontrib><creatorcontrib>Harman, Mehmet</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uzun, Soner</au><au>Gürel, Mehmet S.</au><au>Durdu, Murat</au><au>Akyol, Melih</au><au>Fettahlıoğlu Karaman, Bilge</au><au>Aksoy, Mustafa</au><au>Aytekin, Sema</au><au>Borlu, Murat</au><au>İnan Doğan, Esra</au><au>Doğramacı, Çiğdem Asena</au><au>Kapıcıoğlu, Yelda</au><au>Akman‐Karakaş, Ayşe</au><au>Kaya, Tamer İ.</au><au>Mülayim, Mehmet K.</au><au>Özbel, Yusuf</au><au>Özensoy Töz, Seray</au><au>Özgöztaşı, Orhan</au><au>Yeşilova, Yavuz</au><au>Harman, Mehmet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2018-08</date><risdate>2018</risdate><volume>57</volume><issue>8</issue><spage>973</spage><epage>982</epage><pages>973-982</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Background Cutaneous leishmaniasis (CL) is a vector‐born parasitic disease characterized by various skin lesions that cause disfiguration if healed spontaneously. Although CL has been endemic for many years in the southern regions of Turkey, an increasing incidence in nonendemic regions is being observed due to returning travelers and, more recently, due to Syrian refugees. Thus far, a limited number of national guidelines have been proposed, but no common Turkish consensus has emerged. Objectives The aim of this study was to develop diagnostic and therapeutic guidelines for the management of CL in Turkey. Methods This guideline is a consensus text prepared by 18 experienced CL specialists who have been working for many years in areas where the disease is endemic. The Delphi method was used to determine expert group consensus. Initially, a comprehensive list of items about CL was identified, and consensus was built from feedback provided by expert participants from the preceding rounds. Results Evidence‐based and expert‐based recommendations through diagnostic and therapeutic algorithms according to local availability and conditions are outlined. Conclusion Because CL can mimic many other skin diseases, early diagnosis and early treatment are very important to prevent complications and spread of the disease. The fastest and easiest diagnostic method is the leishmanial smear. The most common treatment is the use of local or systemic pentavalent antimony compounds.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>29663351</pmid><doi>10.1111/ijd.14002</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0011-9059
ispartof International journal of dermatology, 2018-08, Vol.57 (8), p.973-982
issn 0011-9059
1365-4632
language eng
recordid cdi_proquest_miscellaneous_2026415177
source Wiley
subjects Antimony
Antimony compounds
Clinical practice guidelines
Complications
Cutaneous leishmaniasis
Delphi method
Diagnosis
Diagnostic systems
Guidelines
Lesions
Medical treatment
Parasitic diseases
Refugees
Skin diseases
Smear
Vector-borne diseases
title Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T00%3A27%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20practice%20guidelines%20for%20the%20diagnosis%20and%20treatment%20of%20cutaneous%20leishmaniasis%20in%20Turkey&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Uzun,%20Soner&rft.date=2018-08&rft.volume=57&rft.issue=8&rft.spage=973&rft.epage=982&rft.pages=973-982&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.14002&rft_dat=%3Cproquest_cross%3E2066447110%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3532-bbfea5701c92eeebde9e83748e013501646f910aca3b034cdcb4e8dcf2f6b39d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2066447110&rft_id=info:pmid/29663351&rfr_iscdi=true